Would You Like To Book A SmartState Program Speaker?

Click Here

Dr. Kenneth Tew

The John C. West Endowed Chair in Cancer Research

Translational Cancer Therapeutics

  • An international leader in drug discovery and development
  • Awarded NIGMS COBRE grant for $10.5 million
  • Fellow, American Association for the Advancement of Science
  • Recipient, Astellas USA Foundation Award
  • PhD,University of London
  • DSc,Institute of Cancer Research

Dr. Kenneth Tew is an international leader in cancer drug discovery and development. His earlier research was pivotal in the design of treatments for hormone refractory prostate cancer. More recently his research has been instrumental in the late-stage clinical testing of three novel drugs; one shows promise in treating ovarian and lung cancer, and another has potential as a modifier of bone marrow mediated immune function.

Dr. Tew is also working to understand how cancer cells develop resistance to different drugs. As part of that work, discoveries have suggested links between cancer and Alzheimer’s. The creation of a new knockout mouse (genetically engineered with one or more inoperable genes) may provide a useful model for studying these diseases.

Highly respected by his colleagues, Dr. Tew was elected Chair of Drug Discovery & Regulatory Affairs for the American Society for Pharmacology and Experimental Therapeutics (2011-2013) and Chair for the Section of Pharmaceutical Sciences of the American Association for the Advancement of Science (2012-2015).

Connect With SmartState Endowed Chairs To Learn About Their Research And Business Development Opportunities

Click Here